Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Iasi – page 2

225 clinical trials in Iasi, Romania across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Iasi at a glance
225
clinical trials
  • Research sites6
Type of trial
Recruitment status
Quick filters

225 trials in Iasi

Open in trial search

Study on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:BNT327
  • Sponsor:BioNTech SE
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Previously Used Biologic Treatments

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:JNJ-77242113
  • Sponsor:Janssen Cilag International

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB

Cardiac failure

Recruiting

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Study of Elafibranor for Adults with Primary Biliary Cholangitis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Elafibranor
  • Sponsor:Ipsen Bioscience Inc.

Study of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC

Schizophrenia

Recruiting

Study on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:Vafidemstat
  • Sponsor:Oryzon Genomics S.A.

Phase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Siltuximab
  • Sponsor:Amgen Inc.

Phase 2 Study of Imzokitug with drug combination as First‑Line Treatment for Adults with Locally Advanced or Metastatic Non‑Small Cell Lung Cancer (NSCLC)

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:BMS-986340
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Efficacy, Safety, and Tolerability of NBI-1065890 in Adults with Tardive Dyskinesia

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Sponsor:Neurocrine Biosciences Inc.

Other cities in Romania

The busiest research cities in the country

All 65 cities in Romania

Clinical research in Iasi

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on multiple cancer types, including prostate, gastric, lung, and breast cancer. Studies evaluate novel therapies and treatment combinations to improve patient outcomes.

  • Metastatic Prostate Cancer Treatment
  • HER2-positive Gastric Cancer Therapy
  • Advanced Lung Cancer Solutions
  • Breast Cancer Management

Research emphasizes personalized treatment approaches and targeted therapies for specific cancer subtypes.

02 Cardiovascular Studies

Comprehensive research into heart disease prevention and treatment, with trials examining new approaches to reduce cardiovascular risks and improve patient outcomes.

  • Heart Failure Prevention
  • Cardiovascular Disease Management
  • Lipoprotein Studies

Investigations focus on innovative therapeutic combinations and preventive strategies.

03 Dermatology Research

Studies evaluating treatments for chronic skin conditions, particularly focusing on psoriasis and related disorders.

  • Plaque Psoriasis Treatment
  • Psoriatic Arthritis Management
  • Long-term Safety Studies

Research aims to develop more effective therapies for moderate to severe skin conditions.

04 Neurological Disorders

Clinical trials investigating treatments for Alzheimer's disease and associated conditions, focusing on innovative therapeutic approaches.

  • Alzheimer's-related Psychosis
  • Cognitive Function Studies

Research emphasizes symptom management and quality of life improvements.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.